BIO

Bio Rad Laboratories Inc

$379.55

1.86 (0.49%) Today

— up— down

Market Cap

$10.20B+40.5%

Revenue (TTM)

$2.58B+1.4%

Net Income (TTM)

$220.75M-29.6%

EPS (TTM)

8.25-29.6%

Shares Out

26.76M

26.76M

P/E Ratio

45.69

45.69

Forward P/E

39.15

39.15

Open

$379.55

$379.55

Previous Close

$377.69

$377.69

Day Range

$374.79 – $381.56

$374.79 – $381.56

52-Week Range

$236.73 – $396.23

$236.73 – $396.23

Beta

1.08

1.08

Volume

261.68K

261.68K

Avg Volume

313.55K

313.55K

Analyst Rating

Hold

Hold

Exchange

NEW YORK STOCK EXCHANGE, INC.

NEW YORK STOCK EXCHANGE, INC.

About BIO

Related

News

Biodesix Expands MRD Testing With Tumor-Informed and Tumor-Naive Tests

Yahoo · 1d ago

Magnetic Beads - Global Strategic Business Report: Capitalize on the Surge from $3.3 Billion in 2025 to $7.4 Billion by 2032 as Thermo Fisher Scientific, Merck KGaA, QIAGEN, Bio-Rad Laboratories and Miltenyi Biotec Battle for Leadership

Yahoo · 1d ago

Bio-Rad Laboratories Bets on Digital PCR, Margins and Smarter M&A Growth

Yahoo · 4d ago

Bio-Rad Laboratories, Inc. (BIO) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum Transcript

SeekingAlpha · 5d ago

Cell Isolation/Cell Separation Market Forecasts Growth from $6.97B (2026) to $13.51B by 2032, Profiling Thermo Fisher, Bio-Rad, Beckman Coulter & Sartorius

Yahoo · 5d ago